TG Therapeutics Inc (TGTX)
Healthcare
Biotechnology
52.00 $
-2.8%
vs. previous close
Closing price · As of: 31. Jul 2026
TG Therapeutics Inc (TGTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -25 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -35 | -45 | -62 | -94 | -129 | -133 | -215 | -296 | -176 | -31 | -41 | -25 | |
| 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.3 | 0.4 | 0.5 | 0.5 | 0.4 | 0.3 | 0.1 | |
| 21 | 16 | 7.5 | 16 | 13 | 11 | 80 | 61 | 19 | 38 | 43 | 65 | |
| 21 | 16 | 7.4 | 16 | 13 | 11 | 81 | 61 | 19 | – | – | – | |
| -6.0 | 2.1 | 8.8 | 8.6 | 28 | 25 | -20 | -12 | -1.6 | -85 | -109 | -195 | |
| 0.0 | 0.0 | 0.3 | 0.0 | 0.1 | 0.1 | 0.4 | 0.4 | 0.0 | 0.0 | 0.0 | 0.2 | |
| -18 | -25 | 27 | -8.2 | 1.2 | -0.7 | -25 | -0.3 | -20 | -51 | -1.0 | 14 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | – | – | – | – | |
| 69 | 69 | 5.0 | 134 | 114 | 175 | 680 | 2.4 | 0.6 | 0.0 | -8.8 | -91 | |
| -0.7 | -0.1 | 0.0 | 30 | 30 | 29 | 40 | 39 | -1.0 | 25 | 137 | 0.0 | |
| 69 | 69 | 5.0 | 134 | 114 | 204 | 680 | 41 | -0.4 | 73 | 129 | -90 | |
| 15 | -0.7 | -30 | 32 | -14 | 71 | 441 | -255 | -197 | -9.4 | 87 | -101 | |
| -35 | -45 | -62 | -94 | -129 | -133 | -215 | -296 | -176 | -31 | -41 | -25 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.